These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8223909)

  • 1. Isomeric selectivity at dopamine D3 receptors.
    Baldessarini RJ; Kula NS; McGrath CR; Bakthavachalam V; Kebabian JW; Neumeyer JL
    Eur J Pharmacol; 1993 Aug; 239(1-3):269-70. PubMed ID: 8223909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of D3 and sigma receptors in the rat striatum and nucleus accumbens using (+/-)-7-hydroxy-N,N-di-n-[3H]propyl-2-aminotetralin and carbetapentane.
    Wallace DR; Booze RM
    J Neurochem; 1995 Feb; 64(2):700-10. PubMed ID: 7830063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D2 and D3 receptors in the rat striatum and nucleus accumbens: use of 7-OH-DPAT and [125I]-iodosulpride.
    Booze RM; Wallace DR
    Synapse; 1995 Jan; 19(1):1-13. PubMed ID: 7709338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological aspects of R-(+)-7-OH-DPAT, a putative dopamine D3 receptor ligand.
    Damsma G; Bottema T; Westerink BH; Tepper PG; Dijkstra D; Pugsley TA; MacKenzie RG; Heffner TG; Wikström H
    Eur J Pharmacol; 1993 Nov; 249(3):R9-10. PubMed ID: 8287911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of [3H]quinpirole binding to human dopamine D2A and D3 receptors: effects of ions and guanine nucleotides.
    Malmberg A; Mohell N
    J Pharmacol Exp Ther; 1995 Aug; 274(2):790-7. PubMed ID: 7636742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding characteristics of remoxipride and its metabolites to dopamine D2 and D3 receptors.
    Mohell N; Sällemark M; Rosqvist S; Malmberg A; Högberg T; Jackson DM
    Eur J Pharmacol; 1993 Jul; 238(1):121-5. PubMed ID: 8405075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3H]7-OH-DPAT labels both dopamine D3 receptors and sigma sites in the bovine caudate nucleus.
    Schoemaker H
    Eur J Pharmacol; 1993 Oct; 242(3):R1-2. PubMed ID: 8281986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of (R,S)-2'-trans-7-hydroxy-2-[N-n-propyl-N-(3'-iodo-2'- propenyl)-amino]tetralin (trans-7-OH-PIPAT): a new D3 dopamine receptor ligand.
    Foulon C; Kung MP; Kung HF
    J Med Chem; 1993 May; 36(10):1499-500. PubMed ID: 8098771
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro binding of a novel dopamine D3 receptor ligand: [125I]trans-7-OH-PIPAT-A.
    Kung MP; Kung HF; Chumpradit S; Foulon C
    Eur J Pharmacol; 1993 Apr; 235(1):165-6. PubMed ID: 8519278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of [125I](R)-trans-7-hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino] tetralin binding to dopamine D3 receptors in rat olfactory tubercle.
    Burris KD; Filtz TM; Chumpradit S; Kung MP; Foulon C; Hensler JG; Kung HF; Molinoff PB
    J Pharmacol Exp Ther; 1994 Feb; 268(2):935-42. PubMed ID: 8114008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actions of (+/-)-7-hydroxy-N,N-dipropylaminotetralin (7-OH-DPAT) on dopamine synthesis in limbic and extrapyramidal regions of rat brain.
    Booth RG; Baldessarini RJ; Marsh E; Owens CE
    Brain Res; 1994 Oct; 662(1-2):283-8. PubMed ID: 7859086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iodinated 2-aminotetralins and 3-amino-1-benzopyrans: ligands for dopamine D2 and D3 receptors.
    Chumpradit S; Kung MP; Vessotskie J; Foulon C; Mu M; Kung HF
    J Med Chem; 1994 Nov; 37(24):4245-50. PubMed ID: 7990123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]7-OH-DPAT is capable of labeling dopamine D2 as well as D3 receptors.
    Gonzalez AM; Sibley DR
    Eur J Pharmacol; 1995 Jan; 272(1):R1-3. PubMed ID: 7713138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S 14297, a novel selective ligand at cloned human dopamine D3 receptors, blocks 7-OH-DPAT-induced hypothermia in rats.
    Millan MJ; Audinot V; Rivet JM; Gobert A; Vian J; Prost JF; Spedding M; Peglion JL
    Eur J Pharmacol; 1994 Aug; 260(2-3):R3-5. PubMed ID: 7988633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
    Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative affinities of dopaminergic drugs at dopamine D2 and D3 receptors.
    Levant B; Grigoriadis DE; De Souza EB
    Eur J Pharmacol; 1995 May; 278(3):243-7. PubMed ID: 7589161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-(+)-aporphines are not selective for human D3 dopamine receptors.
    Kula NS; Baldessarini RJ; Kebabian JW; Neumeyer JL
    Cell Mol Neurobiol; 1994 Apr; 14(2):185-91. PubMed ID: 7842476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the human dopamine D3 receptor expressed in transfected cell lines.
    MacKenzie RG; VanLeeuwen D; Pugsley TA; Shih YH; Demattos S; Tang L; Todd RD; O'Malley KL
    Eur J Pharmacol; 1994 Jan; 266(1):79-85. PubMed ID: 7907989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative autoradiographic studies of dopamine D3 receptors in rat cerebellum using [125I]S(-)5-OH-PIPAT.
    Vessotskie JM; Kung MP; Chumpradit S; Kung HF
    Brain Res; 1997 Dec; 778(1):89-98. PubMed ID: 9462880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D3 receptor binding by D3 agonist 7-OH-DPAT (7-hydroxy-dipropylaminotetralin) and antipsychotic drugs measured ex vivo by quantitative autoradiography.
    Kaichi Y; Nonaka R; Hagino Y; Watanabe M
    Can J Physiol Pharmacol; 2000 Jan; 78(1):7-11. PubMed ID: 10741754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.